← Leaderboards
Richard Ebright
Harvard Medical School
$118,314
Attributed
$118,314
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $46.3K · FY2018–20$50K$37.5K$25K$12.5K$0
'18
'19
'20
Funding mix
By agency
NIH$118,314 · 1
By mechanism
F30$118,314 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Arlene H Sharpe$68,359,602
- Norbert Perrimon$95,273,017
- Min Dong$19,640,842
- Omar O Abudayyeh$3,693,257
- John Gerard Doench$3,730,510
Others in their field
Other Emerging Leaders on “American”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Mark Marino · Venturewell$48,913,644
- Leonard Freedman · Leidos Biomedical Research, Inc.$42,791,770
- Scott Dahm · Association Of Universities For Research In Astronomy, Inc.$39,961,632
- Robert D Blum · Association Of Universities For Research In Astronomy, Inc.$30,497,056
Research focus
AmericanAbnormal CellBlood CirculationBreastCancer CellBioinformaticsCause Of DeathCell Culture TechniquesCell LineCell PhysiologyCellsCessation Of LifeCancer GeneticsClinically RelevantClinical MedicineClustered Regularly Interspaced Short Palindromic RepeatsCrispr ScreenDatabasesDifferential ExpressionDistalDistantEnvironmentExperimental ModelsExperimental Study
Grant awards (3)
Genome-scale CRISPR activation screening to identify lung-specific metastatic pathways$46,300
F30 · FY2020 · CA · contact PI
Genome-scale CRISPR activation screening to identify lung-specific metastatic pathways$36,253
F30 · FY2019 · CA · contact PI
Genome-scale CRISPR activation screening to identify lung-specific metastatic pathways$35,761
F30 · FY2018 · CA · contact PI